PDG10 COST-EFFECTIVENESS OF CELECOXIB VERSUS IBUPROFEN AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS IN UNITED ARAB EMIRATES AND SAUDI ARABIA BASED ON RESULTS FROM THE PRECISION TRIAL
Abstract
Authors
O.H. Ahmed V. Chirikov C. Walker J.M. Stephens P. Schepman R. Chambers M. Bakir G. Poorman S. Haider